Relay Therapeutics Inc (RLAY) Price Prediction & ForecastRLAYRelay Therapeutics Inc

Alphio's RLAY stock price prediction model matches the current Relay Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $18.82 (+0.27%). The 1-week path is $18.57 (-1.06%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Relay Therapeutics Inc is a good buy right now due to its current price of $18.77, which is significantly below analyst price targets of $29 and $31, indicating potential upside. Additionally, the company has a robust gross margin of 100% and a strong year-to-date change of +129.46%, reflecting its growth potential despite recent insider selling. The main risk is the negative net income, which stands at -83,707,000 USD for Q2 2026, indicating ongoing financial challenges.

Relay Therapeutics Inc (RLAY) last closed at $18.77, losing -3.35%. These facts feed the 1-day and 1-week RLAY price prediction above.